10th Anniversary & Masterclass
Agenda
MPE 10th Anniversary and Masterclass 2021 agenda
2 – 3 July 2021 – Virtual meeting
Friday, 2 July 2021
13:00 – 13:30 | Welcome |
Opening Remarks, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO | |
13.30 – 15.00 | Updates in Multiple Myeloma Diagnosis and Treatment |
The early detection and diagnosis of MGUS and SMM, Marivi Mateos, MD, PhD, Director of the Myeloma Unit at the University Hospital of Salamanca-IBSAL, Spain | |
New developments and controversies in the myeloma treatment pathway, Mohamad Mohty, MD, PhD, Head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital at University Pierre and Marie Curie, Paris, France | |
Moderated Q&A | |
15.00 – 15.15 | Coffee Break |
15.15 – 16.45 | Multiple myeloma patients and patient organizations in the time of COVID-19 |
COVID-19 and the effect on the treatment and care for myeloma and AL amyloidosis patients in Europe, Mohamad Mohty | |
MPE members response to and resiliency during COVID-19, MPE Member Organizations | |
Moderated Q&A | |
16.45 – 17.00 | Wrap-up, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO |
17:00 – 17:30 | Coffee Break |
17:30 – 18:30 | MPE 10th Anniversary Happy Hour! Join us as we cheers to 10 years of MPE, celebrate all that we’ve achieved together, and enjoy a live show from renowned mind reader, Ashley Green! Please note that this is open to MPE members and invited guests only. |
Saturday, 3 July 2021
9:00 – 9:15 | Welcome |
Opening Remarks, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO | |
9.15 – 10.45 | AL Amyloidosis & other MM related diseases |
Developments in AL amyloidosis: diagnostic centres of expertise, treatment pathway, and stages of the disease, Monique Minnema, MD, PhD University Medical Center Utrecht, the Netherlands | |
Myeloma related diseases, their presentation and effects on symptoms and quality of life, Paolo Milani, MD, PhD, University of Pavia, Pavia, Italy | |
Moderated Q&A | |
10.45 – 11.00 | Coffee break |
11.00 – 12.30 | Access to new treatments |
Immunotherapy in the treatment of myeloma and AL amyloidosis, Marivi Mateos | |
A clinical perspective on access in central and eastern European and Balkan countries, Roman Hájek, M.D., Ph.D., University Hospital Ostrava, Czech Republic | |
Moderated Q&A | |
12.30 – 13.30 | Lunch break |
13.30 – 15.00 | Empowering Patient Organisations |
Palliative Care and quality of life, Christina Gerlach, M.D. | |
Fundraising for patient groups and collaboration with industry, Jan Geissler, Chair, Workgroup of European Cancer Patient Advocacy Networks (WECAN) | |
15:00 – 15:15 | Coffee Break |
15.15 – 16.45 | Panel discussion on Minimal Residual Disease (MRD) |
Hans Jacobs, M.D., Ph.D., Medical Immunologist, Radboud University Medical Center, NL | |
Paula van Hennik, Committee for Medicinal Products for Human Use (CHMP) and member at the European Medicine Agency (EMA) | |
Hans Scheurer, MPE President | |
16.45 – 17.00 | Wrap up and close, Hans Scheurer, MPE President, and Ananda Plate, MPE CEO |
Web links